IP Library Patent Application 13645525
Patent Application
App. No. 13/645,525

METHODS FOR EXTRACTING PLATELETS AND COMPOSITIONS OBTAINED THEREFROM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/645,525
Abstract

This invention provides methods for extracting platelets, compositions obtained therefore, and methods for using the same.

Claims (20)

1 . A composition comprising a growth factor produced by a process comprising:

disrupting pelletized platelets in an extraction solution to produce an insoluble material portion and the extraction solution comprising a growth factor; and

removing insoluble materials and proteins having molecular weight of 2 kD or less from said extraction solution to produce a composition comprising a growth factor.

2 . The composition of claim 1 , wherein said method for disrupting pelletized platelets comprises sonication, homogenization, nitrogen cavitation, a French pressure cell, or a combination thereof.

3 . The composition of claim 1 , wherein said step of removing insoluble materials and proteins comprises:

(i) filtering said extraction solution using an ultrafiltration process to remove insoluble materials and proteins having molecular weight of 2 kD or less; or

(ii) removing insoluble materials from said extraction solution; and

(a) dialyzing said extraction solution against an acidic solution using a semipermeable membrane having 2 kD or less MWCO; or

(b) filtering said extraction solution using an ultrafiltration process to remove proteins having molecular weight of 2 kD or less.

4 . The composition of claim 3 , wherein said step of dialyzing comprises using a semipermeable membrane having 8 kD or less MWCO.

5 . The composition of claim 1 , wherein said process further comprises subjecting said extraction solution to an ultrafiltration process to remove any microorganisms that maybe present.

6 . The composition of claim 5 , wherein said process further comprises lyophilizing said extraction solution to produce a solid composition comprising the growth factor.

7 . The composition of claim 6 , wherein said process further comprises dissolving said solid composition in a solution to produce a fluid composition comprising the growth factor.

8 . The composition of claim 1 , wherein said growth factor comprises VEGF, TGF-β 1 , TGF-β 2 , PDGF-BB, EGF, or a mixture thereof.

9 . A wound healing composition comprising therapeutically effective amount of a composition of claim 1 and a pharmaceutically acceptable carrier.

10 . The wound healing composition of claim 9 , wherein said pharmaceutically acceptable carrier comprises a bandage.

11 . The wound healing composition of claim 9 , wherein the pharmaceutically acceptable carrier comprises a pharmaceutically acceptable polymer.

12 . A method for regenerating a tissue or treating a wound comprising contacting a desired site for tissue regeneration or the wound with an angiogenic composition comprising a composition of claim 1 .

13 . The method of claim 12 , wherein the desired site for tissue regeneration comprises a burn site, a graft donor site, an oral and maxillofacial surgery site, a mucogingival surgery site, a perioplastic surgery site, an oral mucosa site, or a combination thereof.

14 . A method for reducing the risk of microbial infection in a wound comprising treating the wound with a wound treatment composition comprising a composition of claim 1 .

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 9, 2018
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045025/0201 →